• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
To Investigate the Effect of Dyslipidemia and Metabolic Function in Coronary Heart Disease with Type 2 Diabetes Mellitus-In the Tertiary Care Center. A Study Protocol.在三级医疗中心研究血脂异常和代谢功能对2型糖尿病合并冠心病的影响:一项研究方案
J Pharm Bioallied Sci. 2025 May;17(Suppl 1):S919-S920. doi: 10.4103/jpbs.jpbs_1963_24. Epub 2025 Mar 6.
2
Diabetic dyslipidemia.糖尿病血脂异常
Am J Cardiol. 1998 Dec 17;82(12A):67U-73U; discussion 85U-86U. doi: 10.1016/s0002-9149(98)00848-0.
3
A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with type 1 (insulin-dependent) diabetes mellitus.1型(胰岛素依赖型)糖尿病合并冠心病患者心血管危险因素的横断面评估。
Diabetes Res Clin Pract. 1992 Dec;18(3):173-84. doi: 10.1016/0168-8227(92)90143-f.
4
Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.阿利西尤单抗治疗 2 型糖尿病合并动脉粥样硬化性心血管疾病患者:ODYSSEY DM-DYSLIPIDEMIA 和 DM-INSULIN 研究分析。
Cardiovasc Diabetol. 2019 Nov 9;18(1):149. doi: 10.1186/s12933-019-0951-9.
5
Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and Type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China.在中国冠心病患者中,甘油三酯/高密度脂蛋白胆固醇比值与其他非传统脂质参数与糖尿病前期和 2 型糖尿病风险的相关性:RCSCD-TCM 研究。
Cardiovasc Diabetol. 2022 Jun 3;21(1):93. doi: 10.1186/s12933-022-01531-7.
6
Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease?血清C反应蛋白浓度与伴有或不伴有冠心病的2型糖尿病男性患者的糖化血红蛋白及胰岛素抵抗相关吗?
J Endocrinol Invest. 2005 Feb;28(2):145-50. doi: 10.1007/BF03345357.
7
Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus.胰岛素依赖型糖尿病患者中与冠心病相关的脂质和脂蛋白异常
Arteriosclerosis. 1986 Nov-Dec;6(6):679-84. doi: 10.1161/01.atv.6.6.679.
8
Management of dyslipidemia in adults with diabetes.糖尿病成人血脂异常的管理
Diabetes Care. 1998 Jan;21(1):160-78. doi: 10.2337/diacare.21.1.160.
9
Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes.脂质和脂蛋白对非胰岛素依赖型糖尿病患者冠心病死亡率和发病率的预测作用
Circulation. 1993 Oct;88(4 Pt 1):1421-30. doi: 10.1161/01.cir.88.4.1421.
10
Dyslipidemia, morbidity, and mortality in non-insulin-dependent diabetes mellitus. Lipoproteins and coronary heart disease in non-insulin-dependent diabetes mellitus.非胰岛素依赖型糖尿病中的血脂异常、发病率和死亡率。非胰岛素依赖型糖尿病中的脂蛋白与冠心病。
J Diabetes Complications. 1997 Mar-Apr;11(2):137-41. doi: 10.1016/s1056-8727(96)00092-x.

本文引用的文献

1
Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.代谢风险因素与心血管疾病及糖尿病发生之间的关系。
Obesity (Silver Spring). 2006 Jun;14 Suppl 3:121S-127S. doi: 10.1038/oby.2006.291.
2
1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.在血糖控制适度的糖尿病患者中,通过连续血糖监测系统测量的1,5-脱水葡萄糖醇与餐后高血糖
Diabetes Care. 2006 Jun;29(6):1214-9. doi: 10.2337/dc06-1910.
3
The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.明斯特前瞻性心血管疾病(PROCAM)研究:高血压和/或糖尿病患者中高脂血症的患病率及其与冠心病的关系。
Am Heart J. 1988 Dec;116(6 Pt 2):1713-24. doi: 10.1016/0002-8703(88)90220-7.

在三级医疗中心研究血脂异常和代谢功能对2型糖尿病合并冠心病的影响:一项研究方案

To Investigate the Effect of Dyslipidemia and Metabolic Function in Coronary Heart Disease with Type 2 Diabetes Mellitus-In the Tertiary Care Center. A Study Protocol.

作者信息

Singh Akansha, Ambad Ranjit S, Jha Roshan Kumar, Jha Rakesh Kumar

机构信息

Department of Biochemistry, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Sawangi (M), Wardha, Maharashtra, India.

出版信息

J Pharm Bioallied Sci. 2025 May;17(Suppl 1):S919-S920. doi: 10.4103/jpbs.jpbs_1963_24. Epub 2025 Mar 6.

DOI:10.4103/jpbs.jpbs_1963_24
PMID:40511010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12156634/
Abstract

INTRODUCTION

Type 2 DM is the most common type of diabetes and it is characterized by a combination of insulin resistance and relative insulin shortage caused by pancreatic beta cell failure. In India, type 2 diabetes affects 2-4% of the rural population and 4-11.03% of the urban population (urban areas). Due to the accumulation of lipoproteins and cholesterol, it forms plug-in veins and it would cause coronary heart disease. CHD is considered a strong risk issue with the presence of various factors, such as HDL, VLDL, and LDL and blood pressure with their age of patients. Fatty acid from adipose tissue enters the liver, where it is converted to acetyl Co A, which then becomes VLDL.

MATERIAL AND METHODS

This would be a cross-sectional study consisting of 100 subjects; distributed into two groups: a) 50 would be type 2 DM with CHD patients, and b) 50 would be nondiabetic with CHD patients. Estimation of the blood sugar level, HbA1c, lipid profile, non-HDL-C and non-LDL-C, insulin resistance, cardiac markers, AST, and ALT were observed.

CONCLUSION

To compare outcome in diabetic and nondiabetic patients with CHD in the eastern region of Maharashtra in the tertiary care center with respect to postoperative morbidity, early mortality, and long-term survival. The present study will be helpful to reveal the heightened risk of CHD in type 2 DM patients due to dyslipidemia and metabolic disorders, emphasizing the need for targeted prevention and management strategy.

摘要

引言

2型糖尿病是最常见的糖尿病类型,其特征是胰岛素抵抗与胰腺β细胞功能衰竭导致的相对胰岛素缺乏并存。在印度,2型糖尿病影响2%至4%的农村人口以及4%至11.03%的城市人口(城市地区)。由于脂蛋白和胆固醇的积累,会形成静脉栓塞并引发冠心病。冠心病被认为是一个严重的风险问题,存在多种影响因素,如高密度脂蛋白(HDL)、极低密度脂蛋白(VLDL)、低密度脂蛋白(LDL)以及患者年龄和血压等。来自脂肪组织的脂肪酸进入肝脏,在那里转化为乙酰辅酶A,然后变成极低密度脂蛋白。

材料与方法

这将是一项横断面研究,包括100名受试者;分为两组:a)50名2型糖尿病合并冠心病患者,b)50名非糖尿病冠心病患者。观察血糖水平、糖化血红蛋白(HbA1c)、血脂谱、非高密度脂蛋白胆固醇(non-HDL-C)和非低密度脂蛋白胆固醇(non-LDL-C)、胰岛素抵抗、心脏标志物、谷草转氨酶(AST)和谷丙转氨酶(ALT)的测定结果。

结论

在三级护理中心比较马哈拉施特拉邦东部地区糖尿病和非糖尿病冠心病患者在术后发病率、早期死亡率和长期生存率方面的结果。本研究将有助于揭示2型糖尿病患者因血脂异常和代谢紊乱而增加的冠心病风险,强调针对性预防和管理策略的必要性。